APA 6th Edition

F. Muresanu, D. (2012). Monomodal versus Multimodal Drugs in Brain Protection and Recovery. Acta clinica Croatica, 51 (Supplement 2), 26-26. Preuzeto s https://hrcak.srce.hr/index.php/106293

---

MLA 8th Edition

F. Muresanu, Dafin. "Monomodal versus Multimodal Drugs in Brain Protection and Recovery." Acta clinica Croatica, vol. 51, br. Supplement 2, 2012, str. 26-26. https://hrcak.srce.hr/index.php/106293. Citirano 03.01.2025.

---

Chicago 17th Edition

F. Muresanu, Dafin. "Monomodal versus Multimodal Drugs in Brain Protection and Recovery." Acta clinica Croatica 51, br. Supplement 2 (2012): 26-26. https://hrcak.srce.hr/index.php/106293

---

Harvard

F. Muresanu, D. (2012). 'Monomodal versus Multimodal Drugs in Brain Protection and Recovery', Acta clinica Croatica, 51(Supplement 2), str. 26-26. Preuzeto s: https://hrcak.srce.hr/index.php/106293 (Datum pristupa: 03.01.2025.)

---

Vancouver

F. Muresanu D. Monomodal versus Multimodal Drugs in Brain Protection and Recovery. Acta clinica Croatica [Internet]. 2012 [pristupljeno 03.01.2025.];51(Supplement 2):26-26. Dostupno na: https://hrcak.srce.hr/index.php/106293

---

IEEE

D. F. Muresanu, "Monomodal versus Multimodal Drugs in Brain Protection and Recovery", Acta clinica Croatica, vol.51, br. Supplement 2, str. 26-26, 2012. [Online]. Dostupno na: https://hrcak.srce.hr/index.php/106293. [Citirano: 03.01.2025.]